The Psoriasis Drugs Market is witnessing significant expansion as the global burden of autoimmune disorders rises. Increasing awareness, early diagnosis, and advancements in biologics are reshaping treatment landscapes. The market is projected to grow steadily through 2033, supported by innovations in targeted therapies and improved patient outcomes worldwide. Psoriasis affects millions...